ESH Video


October 25, 2022


3rd How to Diagnose and Treat



November 04-06, 2022

Paris, France




#ESHLYMPHOMA2022 is only 10 days away!
The Conference will start on
Friday, November 4th at 08:25 am CET

It's time to register!
Proceed now and join our faculty in Paris
The ESH team is looking forward to welcoming you!


Join our international faculty of global experts!



About the Conference:

ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.
They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.

This How to Diagnose and Treat conference will bring together biologists and clinicians with an interest in Lymphoma in order to explore the most recent advances in the understanding of the pathogenesis and clinical behaviour of the disease.

New data will be presented and spirited debates on how to best apply these insights to the future of Lymphoma therapy are expected.


Conference scientific topics:

• Hodgkin’s Lymphoma

• T-cell Lymphoma

• Follicular Lymphoma

• Aggressive B-Cell Lymphomas

• Large B-Cell Lymphoma, Practical Management

• Uncommon Lymphomas— Waldenstrom’s Macroglobulinemia,

Marginal zone lymphoma, Mantle cell lymphoma


Learning objectives:

• Understand recent advances in elucidating the pathogenesis of lymphoma

• Describe recent data on therapeutic regimens for lymphoma

• Understand emerging data on mechanisms of resistance to targeted agents in lymphoma

• Understand the debate about how best to optimize lymphoma therapy in the future


The programme will include:

Plenary Sessions - Interactive Case Presentations

Roundtables - Panel Discussions - Debates

Meet the Expert Sessions - Poster Walks - Voting technology


For more information, click here!



With the support of*:



Major Conference Partners

Level 1 Conference Partners

Supporting Conference Partner

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.